Abstract
Extracorporeal membrane oxygenation (ECMO) has been a successful treatment (82% survival) in over 5000 neonates with severe respiratory failure (80% predicted mortality without ECMO). ECMO is prolonged extracorporeal cardiopulmonary bypass achieved by extrathoracic vascular cannulation using a modified heart-lung machine. ECMO is currently the treatment of choice for full-term newborns with severe respiratory failure. The report summarizes indications, resulting complications, and future applications of neonatal ECMO.
| Original language | English |
|---|---|
| Pages (from-to) | 316-322 |
| Number of pages | 7 |
| Journal | Thoracic and Cardiovascular Surgeon |
| Volume | 40 |
| Issue number | 6 |
| DOIs | |
| State | Published - 1992 |
Keywords
- Extracorporeal Life Support Organization
- complications
- extracorporeal oxygenation
- indications
- membrane oxygenation
ASJC Scopus subject areas
- Surgery
- Pulmonary and Respiratory Medicine
- Cardiology and Cardiovascular Medicine